These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 8169005)

  • 1. Regulation of cell survival in Burkitt lymphoma: implications from studies of apoptosis following cold-shock treatment.
    Gregory CD; Milner AE
    Int J Cancer; 1994 May; 57(3):419-26. PubMed ID: 8169005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of programmed cell death in Burkitt lymphoma cell lines by bcl-2-dependent and -independent mechanisms.
    Milner AE; Johnson GD; Gregory CD
    Int J Cancer; 1992 Oct; 52(4):636-44. PubMed ID: 1328074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apoptosis in Burkitt lymphoma cells is driven by c-myc.
    Milner AE; Grand RJ; Waters CM; Gregory CD
    Oncogene; 1993 Dec; 8(12):3385-91. PubMed ID: 8247541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Irradiated fibroblasts protect Burkitt lymphoma cells from apoptosis by a mechanism independent of bcl-2.
    Falk MH; Hültner L; Milner A; Gregory CD; Bornkamm GW
    Int J Cancer; 1993 Sep; 55(3):485-91. PubMed ID: 8397166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD40-triggered protein tyrosine phosphorylation on Vav and on phosphatidylinositol 3-kinase correlates with survival of the Ramos-Burkitt lymphoma B cell line.
    Padmore L; An S; Gunby RH; Kelly K; Radda GK; Knox KA
    Cell Immunol; 1997 May; 177(2):119-28. PubMed ID: 9178638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Germinal center-derived signals act with Bcl-2 to decrease apoptosis and increase clonogenicity of drug-treated human B lymphoma cells.
    Walker A; Taylor ST; Hickman JA; Dive C
    Cancer Res; 1997 May; 57(10):1939-45. PubMed ID: 9157989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transforming growth factor-beta 1 cooperates with anti-immunoglobulin for the induction of apoptosis in group I (biopsy-like) Burkitt lymphoma cell lines.
    MacDonald I; Wang H; Grand R; Armitage RJ; Fanslow WC; Gregory CD; Gordon J
    Blood; 1996 Feb; 87(3):1147-54. PubMed ID: 8562941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ligation of CD40 potentiates Fas-mediated activation of the cysteine protease CPP32, cleavage of its death substrate PARP, and apoptosis in Ramos-Burkitt lymphoma B cells.
    An S; Yap D; Knox KA
    Cell Immunol; 1997 Nov; 181(2):139-52. PubMed ID: 9398401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apoptosis in Burkitt lymphoma cells is prevented by promotion of cysteine uptake.
    Falk MH; Meier T; Issels RD; Brielmeier M; Scheffer B; Bornkamm GW
    Int J Cancer; 1998 Feb; 75(4):620-5. PubMed ID: 9466666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TGFbeta-mediated apoptosis of Burkitt's lymphoma BL41 cells is associated with the relocation of mitochondrial BimEL.
    Clybouw C; Mchichi BE; Hadji A; Portier A; Auffredou MT; Arnoult D; Leca G; Vazquez A
    Oncogene; 2008 May; 27(24):3446-56. PubMed ID: 18193085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transfection of the c-myc oncogene into normal Epstein-Barr virus-harboring B cells results in new phenotypic and functional features resembling those of Burkitt lymphoma cells and normal centroblasts.
    Cutrona G; Ulivi M; Fais F; Roncella S; Ferrarini M
    J Exp Med; 1995 Feb; 181(2):699-711. PubMed ID: 7836923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro suppression of programmed cell death of B cells by tissue inhibitor of metalloproteinases-1.
    Guedez L; Stetler-Stevenson WG; Wolff L; Wang J; Fukushima P; Mansoor A; Stetler-Stevenson M
    J Clin Invest; 1998 Dec; 102(11):2002-10. PubMed ID: 9835626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD95-mediated apoptosis in Burkitt's lymphoma B-cells is associated with Pim-1 down-regulation.
    Matou-Nasri S; Rabhan Z; Al-Baijan H; Al-Eidi H; Yahya WB; Al Abdulrahman A; Almobadel N; Alsubeai M; Al Ghamdi S; Alaskar A; AlBalwi M; Alzahrani M; Alabdulkareem I
    Biochim Biophys Acta Mol Basis Dis; 2017 Jan; 1863(1):239-252. PubMed ID: 27641442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Burkitt lymphoma is immunophenotypically different from Burkitt-like lymphoma in young persons.
    Hutchison RE; Finch C; Kepner J; Fuller C; Bowman P; Link M; Schwenn M; Laver J; Desai S; Barrett D; Murphy SB
    Ann Oncol; 2000; 11 Suppl 1():35-8. PubMed ID: 10707776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Burkitt's lymphoma cells are resistant to programmed cell death in the presence of the Epstein-Barr virus latent antigen EBNA-4.
    Silins SL; Sculley TB
    Int J Cancer; 1995 Jan; 60(1):65-72. PubMed ID: 7814154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination of SAHA and bortezomib up-regulates CDKN2A and CDKN1A and induces apoptosis of Epstein-Barr virus-positive Wp-restricted Burkitt lymphoma and lymphoblastoid cell lines.
    Hui KF; Leung YY; Yeung PL; Middeldorp JM; Chiang AK
    Br J Haematol; 2014 Dec; 167(5):639-50. PubMed ID: 25155625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wild-type p53-triggered apoptosis is inhibited by bcl-2 in a v-myc-induced T-cell lymphoma line.
    Wang Y; Szekely L; Okan I; Klein G; Wiman KG
    Oncogene; 1993 Dec; 8(12):3427-31. PubMed ID: 8247547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel protein expressed in mammalian cells undergoing apoptosis.
    Grand RJ; Milner AE; Mustoe T; Johnson GD; Owen D; Grant ML; Gregory CD
    Exp Cell Res; 1995 Jun; 218(2):439-51. PubMed ID: 7796880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bax is frequently compromised in Burkitt's lymphomas with irreversible resistance to Fas-induced apoptosis.
    Gutiérrez MI; Cherney B; Hussain A; Mostowski H; Tosato G; Magrath I; Bhatia K
    Cancer Res; 1999 Feb; 59(3):696-703. PubMed ID: 9973220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High expression of apoptosis-regulating proteins in Burkitt's lymphomas.
    Pagnano KB; Silva MD; Vassallo J; Souza MS; Costa FF; Saad ST
    Haematologica; 2002 Mar; 87(3):ELT16. PubMed ID: 11869962
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.